Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS).

Dowdell KC, Pesnicak L, Hoffmann V, Steadman K, Remaley AT, Cohen JI, Straus SE, Rao VK.

Exp Hematol. 2009 Apr;37(4):487-94. doi: 10.1016/j.exphem.2008.12.002. Epub 2009 Feb 12.

3.

Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.

Jackson CE, Puck JM.

Curr Opin Pediatr. 1999 Dec;11(6):521-7. Review.

PMID:
10590910
4.
5.

Autoimmunity in mice bearing lprcg: a novel mutant gene.

Kimura M, Matsuzawa A.

Int Rev Immunol. 1994;11(3):193-210. Review.

PMID:
7930845
6.

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.

Rieux-Laucat F, Le Deist F, Fischer A.

Cell Death Differ. 2003 Jan;10(1):124-33. Review.

7.

Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.

van der Werff ten Bosch J, Otten J, Thielemans K.

Leuk Lymphoma. 2001 May;41(5-6):501-11. Review.

PMID:
11378568
8.

[The role of CD95 (APO-1/Fas) mutations in lymphoproliferative and malignant lymphatic diseases].

Beltinger C, Böhler T, Schrappe M, Ludwig WD, Debatin KM.

Klin Padiatr. 1998 Jul-Aug;210(4):153-8. Review. German.

PMID:
9743945
9.

[The autoimmune lymphoproliferative syndrome: a disorder of programmed cell death].

Seegers D, Peña AS, Bouma G.

Ned Tijdschr Geneeskd. 2004 Feb 21;148(8):371-6. Review. Dutch.

PMID:
15032090
10.

Autoimmune lymphoproliferative syndrome: etiology, diagnosis, and management.

van der Werff ten Bosch J.

Paediatr Drugs. 2003;5(3):185-93. Review.

PMID:
12608883
11.

[Autoimmune lymphoproliferative syndrome(ALPS)].

Kasahara Y.

Ryoikibetsu Shokogun Shirizu. 2000;(31):168-71. Review. Japanese. No abstract available.

PMID:
11269048
12.

Autoimmune lymphoproliferative syndrome: an update and review of the literature.

Shah S, Wu E, Rao VK, Tarrant TK.

Curr Allergy Asthma Rep. 2014 Sep;14(9):462. doi: 10.1007/s11882-014-0462-4. Review.

13.

Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.

George LA, Teachey DT.

Paediatr Drugs. 2016 Aug;18(4):261-72. doi: 10.1007/s40272-016-0175-3. Review.

PMID:
27139496
14.

The expanding spectrum of the autoimmune lymphoproliferative syndromes.

Oliveira JB.

Curr Opin Pediatr. 2013 Dec;25(6):722-9. doi: 10.1097/MOP.0000000000000032. Review.

15.

Autoimmune lymphoproliferative syndrome: more than a FAScinating disease.

Bride K, Teachey D.

F1000Res. 2017 Nov 1;6:1928. doi: 10.12688/f1000research.11545.1. eCollection 2017. Review.

16.
17.

What's up in the ALPS.

Rieux-Laucat F.

Curr Opin Immunol. 2017 Oct 23;49:79-86. doi: 10.1016/j.coi.2017.10.001. [Epub ahead of print] Review.

PMID:
29073495

Supplemental Content

Support Center